Muise AM, Snapper SB, Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology 2012;143:285-288.
Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 2014;147:990-1007. Outstanding and comprehensive description of gene variants and monogenic diseases giving rise to IBD-like phenotype. A diagnostic strategy is also proposed.
Stamatakos M, Douzinas E, Stefanaki C, et al. Ischemic colitis: surging waves of update. Tohoku J Exp Med 2009;218:83-92.
Freeman HJ. Relevance of segmental colitis with diverticulosis (SCAD) to other forms of inflammatory bowel disease. Can J Gastroenterol 2009;23:439-440.
Selbst MK, Ahrens WA, Robert ME, et al. Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil. Mod Pathol 2009;22:737-743.
Dilauro S, Crum-Cianflone NF. Ileitis: when it is not Crohn's disease. Curr Gastroenterol Rep 2010;12:249-258.
Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423-439.
Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009;58:1490-1497.
Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-1321.
Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 2012;143:347-355.
Zeissig Y, Petersen BS, Milutinovic S, et al. XIAP variants in male Crohn's disease. Gut 2015;64:66-76.
Cheng LE, Kanwar B, Tcheurekdjian H, et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol 2009;132:124-131.
Blaydon DC, Biancheri P, Di WL, et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 2011;365:1502-1508.
Schappi MG, Smith VV, Goldblatt D, et al. Colitis in chronic granulomatous disease. Arch Dis Child 2001;84:147-151.
Dhillon SS, Fattouh R, Elkadri A, et al. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology 2014;147:680-689. Example of monogenic disease with full description of its clinical presentation. This work illustrates the similarity between specific monogenic disease and IBD.
Uzel G, Orange JS, Poliak N, et al. Complications of tumor necrosis factoralpha blockade in chronic granulomatous disease-related colitis. Clin Infect Dis 2010;51:1429-1434.
Meissner F, Seger RA, Moshous D, et al. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 2010;116:1570-1573.
Kato K, Kojima Y, Kobayashi C, et al. Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection. Int J Hematol 2011;94:479-482.
Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol 2013;131:825-830; e9.
Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-21.
Baik SJ, Kim TH, Yoo K, et al. Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report. World J Gastroenterol 2012;18:4233-4236.
Santoro-Lopes G, De Lemos Ados S, Halpern M, et al. Simultaneous cytomegalovirus and Mycobacterium tuberculosis infection presenting as hemorrhagic colitis 3 years after a kidney transplant. Exp Clin Transplant 2011;9:340-343.
Maker AV, Phan GQ, Attia P, et al. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin-2: a phase I/II study. Ann Surg Oncol 2005;12:1005-1016.
Phan GQ, Weber JS, Sondak VK. CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues. Ann Surg Oncol 2008;15:3014-3021.
Burdine L, Lai K, Laryea JA. Ipilimumab-induced colonic perforation. J Surg Case Rep 2014;2014:. doi: 10.1093/jscr/rju010.
Beck KE, Blansfield JA, Tran KQ, et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 2006; M4:2283-2289.
Weng MT, Wei SC, Lin CC, et al. Seminar Report from the 2014 Taiwan Society of Inflammatory Bowel Disease (TSIBD) Spring Forum (May 24th, 2014): Crohn's disease versus intestinal tuberculosis infection. Intest Res 2015;13:6-10. Excellent review highlighting epidemiological aspects of intestinal tuberculosis in endemic countries. It also emphasizes the key elements that help making the differential diagnosis between intestinal tuberculosis and Crohn's disease.
Hisabe T, Hirai F, Matsui T, Watanabe M. Evaluation of diagnostic criteria for Crohn's disease in Japan. J Gastroenterol 2014;49:93-99.
Baron L, Branca G, Trombetta C, et al. Intestinal anisakidosis: histopathological findings and differential diagnosis. Pathol Res Pract 2014;210:746-750.
Passam FH, Diamantis ID, Perisinaki G, et al. Intestinal ischemia as the first manifestation of vasculitis. Semin Arthritis Rheum 2004;34:431-441.
Ali FN, Ishaque S, Jamil B, et al. Sclerosing mesenteritis as a cause of abdominal mass and discomfort in an elderly patient: a case report and literature review. Case Rep Med 2010;2010:625321.
Postal A, Detry O, Louis E, et al. Ileo-caecal actinomycosis: report of a case simulating complicated inflammatory bowel disease. Acta Gastroenterol Belg 2001;64:318-320.
Flicek KT, Vikram HR, De Petris GD, Johnson CD. Abdominal imaging findings in gastrointestinal basidiobolomycosis. Abdom Imaging 2015;40:246-250.
Trifan A, Stanciu C, Stoica O, et al. Impact of clostridium difficile infection on inflammatory bowel disease outcome: a review. World J Gastroenterol 2014;20:11736-11742. Up-to-date review of the clinical impact and clinical course of C. difficile infection in patients with IBD.
Sager K, Alam S, Bond A, et al. Review article: cytomegalovirus and inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:725-733. Up-to-date review of the role of CMV superinfection in IBD and particularly in acute severe colitis. The role of CMV is still debated and this review is important because it gives the arguments on when to treat or not to treat this infection.
Ison MG. Diagnosis of gastrointestinal cytomegalovirus infections: an imperfect science. Clin Infect Dis 2013;57:1560-1561.
Hoeffel C, Crema MD, Belkacem A, et al. Multidetector row CT: spectrum of diseases involving the ileocecal area. Radiographics 2006;26:1373-1390.
Solem CA, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Small intestinal adenocarcinoma in Crohn's disease: a case-control study. Inflamm Bowel Dis 2004;10:32-35.
Hsu EY, Feldman JM, Lichtenstein GR. Ileal carcinoid tumors stimulating Crohn's disease: incidence among 176 consecutive cases of ileal carcinoid. Am J Gastroenterol 1997;92:2062-2065.
